-
-
-
-
-
-
-
-
Jakavi 15mg (Ruxolitinib) ₨ 547,392
Jakavi is indicated for the treatment of adult patients with polycythemia vera who are resistant to or intolerant of hydroxyurea.
-
Jakavi 5mg (Ruxolitinib) ₨ 217,000
Jakavi is indicated for the treatment of adult patients with polycythemia vera who are resistant to or intolerant of hydroxyurea.
-
-
-
Afinitor 10mg (everolimus)
₨ 495,000
DON PLUS CAP – Arthritis
₨ 150
Femara (letrozole) 2.5mg
₨ 13,000
GLIVEC 100mg (imatinib mesylate)
₨ 80,400
GLIVEC 400mg (imatinib mesylate)
₨ 142,000
Jakavi 15mg (Ruxolitinib)
₨ 547,392
Jakavi 5mg (Ruxolitinib)
₨ 217,000
KISQALI 200mg (ribociclib)
₨ 577,884
